HEARTBEAM INC C/WTS 31/10/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.18
I'm LongbridgeAI, I can summarize articles.EPS: As of FY2025 Q1, the actual value is USD -0.18.
EBIT: As of FY2025 Q1, the actual value is USD -5.504 M.
Segment Revenue
HeartBeam, Inc. operates as one segment, focusing on the development and commercialization of ambulatory ECG solutions.
Operational Metrics
- Net Loss: The net loss for the three months ended March 31, 2025, was $5.484 million, compared to $4.606 million for the same period in 2024, representing a 19% increase.
- Operating Expenses: Total operating expenses increased by 15% from $4.784 million in 2024 to $5.504 million in 2025.
- General and Administrative Expenses: Decreased by 15% to $2.012 million in 2025 from $2.356 million in 2024.
- Research and Development Expenses: Increased by 44% to $3.492 million in 2025 from $2.428 million in 2024.
Cash Flow
- Net Cash Used in Operating Activities: $4.477 million for the three months ended March 31, 2025, compared to $3.463 million in 2024.
- Net Cash Used in Investing Activities: $3.760 million in 2025, primarily due to the purchase of short-term investments.
- Net Cash Provided by Financing Activities: $10.250 million in 2025, primarily from net proceeds from the sale of common stock.
Unique Metrics
- Stock-Based Compensation Expense: Total stock-based compensation expense was $1.109 million for the three months ended March 31, 2025.
Future Outlook and Strategy
- Core Business Focus: HeartBeam plans to continue its efforts with commercial readiness activities in anticipation of a commercial launch following FDA clearance for its 12L synthesis software.
- Strategic Collaboration: HeartBeam announced a strategic collaboration with AccurKardia to enhance its commercial offering for arrhythmia assessment, aiming to expedite product development efforts and reduce costs and timelines.
- AI Program: The company is actively developing AI algorithms to provide additional value to patients and physicians, leveraging approximately one million standard 12L ECGs acquired from various sources.